DEXCEL

Serial Number 74713720
Registration 2510743
800

Registration Progress

Application Filed
Aug 10, 1995
Under Examination
Feb 16, 1999
Approved for Publication
Mar 8, 1996
Published for Opposition
Apr 9, 1996
Registered
Nov 20, 2001

Trademark Image

DEXCEL

Basic Information

Serial Number
74713720
Registration Number
2510743
Filing Date
August 10, 1995
Registration Date
November 20, 2001
Published for Opposition
April 9, 1996
Renewal Date
November 20, 2021
Drawing Code
1000

Status Summary

Current Status
Active
Status Code
800
Status Date
Apr 21, 2022
Registration
Registered
Classes
005

Rights Holder

DEXCEL PHARMA TECHNOLOGIES LTD.

16
Address
21 Nahum Haftzadi St.
Jerusalem 9123901
IL

Ownership History

DEXCEL LTD.

Original Applicant
11
Hadera 38100 IL

DEXCEL LTD.

Owner at Publication
11
Hadera 38100 IL

DEXCEL LTD.

Original Registrant
11
Hadera 38100 IL

DEXCEL PHARMA TECHNOLOGIES LTD.

New Owner After Registration #1
16
Jerusalem IL

Legal Representation

Attorney
SEBASTIAN LOVERA

USPTO Deadlines

Next Deadline
2202 days remaining
Section 8 & 9 (30-Year) Renewal Due (Based on registration date 2001-11-20)
Due Date
November 20, 2031
Grace Period Ends
May 20, 2032

Application History

39 events
Date Code Type Description Documents
Dec 20, 2022 COAR I TEAS CHANGE OF OWNER ADDRESS RECEIVED Loading...
Dec 20, 2022 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Loading...
Dec 20, 2022 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Loading...
Dec 20, 2022 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
Dec 20, 2022 CHAN I APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED Loading...
Apr 21, 2022 89AG O REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED Loading...
Apr 21, 2022 RNL2 Q REGISTERED AND RENEWED (SECOND RENEWAL - 10 YRS) Loading...
Apr 21, 2022 NA89 E NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED Loading...
Apr 15, 2022 EROP I TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED Loading...
Mar 18, 2022 PR89 O POST REGISTRATION ACTION MAILED - SEC. 8 & 9 Loading...
Mar 15, 2022 APRE A CASE ASSIGNED TO POST REGISTRATION PARALEGAL Loading...
Nov 9, 2021 E89R I TEAS SECTION 8 & 9 RECEIVED Loading...
Nov 20, 2020 REM2 E COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED Loading...
Feb 11, 2015 ASCK I ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY Loading...
Nov 28, 2011 89AG O REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED Loading...
Nov 28, 2011 RNL1 Q REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS) Loading...
Nov 21, 2011 E89R I TEAS SECTION 8 & 9 RECEIVED Loading...
Aug 10, 2007 PLGL A ASSIGNED TO PARALEGAL Loading...
Aug 10, 2007 C15A O REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK. Loading...
Jul 23, 2007 E815 I TEAS SECTION 8 & 15 RECEIVED Loading...
Jul 23, 2007 815F I REGISTERED - SEC. 8 (6-YR) & SEC. 15 FILED Loading...
Jan 17, 2007 CFIT O CASE FILE IN TICRS Loading...
Nov 20, 2001 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Mar 28, 2001 CNPR P ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED Loading...
Mar 26, 2001 DOCK D ASSIGNED TO EXAMINER Loading...
Mar 22, 2001 SUPC I STATEMENT OF USE PROCESSING COMPLETE Loading...
Feb 16, 2001 IUAF S USE AMENDMENT FILED Loading...
Oct 10, 2000 EX3G S SOU EXTENSION 3 GRANTED Loading...
Aug 15, 2000 EXT3 S SOU EXTENSION 3 FILED Loading...
Apr 14, 2000 EX2G S SOU EXTENSION 2 GRANTED Loading...
Feb 15, 2000 EXT2 S SOU EXTENSION 2 FILED Loading...
Aug 30, 1999 EX1G S SOU EXTENSION 1 GRANTED Loading...
Jul 22, 1999 EXT1 S SOU EXTENSION 1 FILED Loading...
Feb 16, 1999 NOAM O NOA MAILED - SOU REQUIRED FROM APPLICANT Loading...
May 6, 1996 ETOF T EXTENSION OF TIME TO OPPOSE RECEIVED Loading...
Apr 9, 1996 PUBO A PUBLISHED FOR OPPOSITION Loading...
Mar 8, 1996 NPUB O NOTICE OF PUBLICATION Loading...
Feb 6, 1996 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Jan 30, 1996 DOCK D ASSIGNED TO EXAMINER Loading...

Detailed Classifications

Class 005
pharmaceutical preparations for the treatment of cardiovascular,[ central nervous system, ]alimentary system, musculo-skeletal, respiratory, [opthalmic, dermatological, anesthetic, contraceptive and endocrine] disorders; pharmaceutical preparations for the treatment of anti-infective, [nutrition, metabolic and diagnostic] problems
First Use Anywhere: 20000900
First Use in Commerce: 20000900

Classification

International Classes
005